NCT04283201View on ClinicalTrials.gov

Type 2 Diabetes Mellitus Prevention Ukraine

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 20, 2020

Primary Completion Date

November 1, 2021

Study Completion Date

December 31, 2021

Conditions
Impaired Fasting GlucoseImpaired Glucose ToleranceType 2 Diabetes
Interventions
OTHER

Physical activity

Moderate activity 150 min per week

OTHER

Macronutrient modification

Insoluble dietary fiber 15 g per day (Vitacel wheat fiber); sugar limitation

Trial Locations (1)

04114

V.P.Komisarenko Institute of Endocrinology and Metabolism, Kyiv

All Listed Sponsors
lead

Komisarenko Institute of Endocrinology and Metobolism

OTHER_GOV

NCT04283201 - Type 2 Diabetes Mellitus Prevention Ukraine | Biotech Hunter | Biotech Hunter